$0.6444
-0.0038-0.59%
Ult. Agg.: Oct 26, 5:31 PM
Milestone Pharmaceuticals (MIST) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.19 | $0.14 | $-0.18 | $-0.17 |
| Actual | $-0.21 | $-0.20 | $-0.16 | $-0.12 |
| Surprise | -10.5% | -242.9% | +11.1% | +29.4% |
| Revenue | ||||
| Estimate | $813336 | $45.1M | $1.2M | $400000 |
| Actual | $559000 | $238000 | $1.5M | $0 |
| Surprise | -31.3% | -99.5% | +28.8% | -100.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.21 | $-0.23 | $-0.23 | $-0.23 |
| Revenue | ||||
| Consensus | $1.0M | $1.9M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.21 | $-0.19 | -10.5 % |
| Q1 | May 13, 2026 | $-0.20 | $0.14 | -242.9 % |
| Q4 | Mar 20, 2026 | $-0.16 | $-0.18 | 11.1 % |
| Q3 | Nov 12, 2025 | $-0.12 | $-0.17 | 29.4 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $559.00K | $813.34K | -31.3 % |
| Q1 | May 13, 2026 | $238.00K | $45.13M | -99.5 % |
| Q4 | Mar 20, 2026 | $1.55M | $1.20M | 28.8 % |
| Q3 | Nov 12, 2025 | $0 | $400.00K | -100.0 % |